AquaBounty Technologies, Inc. (AQB)
AquaBounty Technologies, Inc. operates in the Agricultural Farm Products industry of the Consumer Defensive sector, headquartered in Maynard, MA, US. The stock last traded at $1.50, up 0.34% on the session, giving a market capitalisation of $7.7M. On trailing twelve-month figures it carries a trailing P/E of -0.33, a net margin of 0.0%. Its beta of 1.39 implies it has historically moved more than the broad market.
AquaBounty Technologies, Inc. is a biotechnology firm dedicated to boosting productivity within the commercial fish farming sector across the United States and Canada. The company's research initiatives delve into genetics, genomics, fish health, and nutrition. Its flagship offering is AquAdvantage Salmon, a genetically engineered Atlantic salmon intended for human consumption. Beyond this, AquaBounty also supplies conventional Atlantic salmon, along with salmon eggs, juvenile fish (fry), and various byproducts. Established in 1991, the firm maintains its headquarters in Maynard, Massachusetts. It operated under the name Aqua Bounty Farms, Inc. until its rebranding in June 2004.
AquaBounty Technologies, Inc. is most often compared with the following Consumer Defensive names: